Don’t miss the latest developments in business and finance.

AstraZeneca Pharma India reports Q3 net loss at Rs 13 crore

Company's standalone total income from operations stood at Rs 108.20 crore for the quarter under consideration

Press Trust of India New Delhi
Last Updated : Feb 12 2015 | 4:30 PM IST
AstraZeneca Pharma India today reported a standalone net loss of Rs 13.40 crore for the third quarter ended December 2014.

The company had reported a net profit of Rs 1.51 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma said in a filing to BSE.

The company's standalone total income from operations stood at Rs 108.20 crore for the quarter under consideration.

Also Read

It was Rs 118.95 crore for the same period a year ago.

Shares of AstraZeneca Pharma India were trading 0.18% down at Rs 867 per scrip during afternoon session on the BSE.

More From This Section

First Published: Feb 12 2015 | 3:20 PM IST

Next Story